期刊文献+

HCV胞膜蛋白E2基因的融合表达、纯化及多克隆抗体制备

The Fusion Expression and Purification of HCV Envelop Protein E2 and Preparation of Its Polyclonal Antibody
下载PDF
导出
摘要 目的原核表达HCV胞膜蛋白E2,获得抗E2多克隆抗体。方法利用PCR方法从HCV基因组序列中扩增出831bp(384~661aa)的E2基因片段并按读框克隆到原核表达载体pET32a(+),IPTG诱导HCVE2蛋白表达,SDS-PAGE和WesternBlot法检测蛋白表达,Ni-NTA偶联的琼脂糖吸附柱纯化融合蛋白,薄层扫描及Bradford法检测纯化蛋白的纯度>90%;用表达的E2蛋白免疫新西兰兔制备多克隆抗体,利用间接ELISA法检测抗体效价,WesternBlot法检测抗体特异性。结果用原核诱导表达出HCV胞膜蛋白E2免疫新西兰兔后获得多克隆抗体的效价在1∶1280以上,能特异性识别E2蛋白。结论成功构建HCVE2基因的原核表达载体,利用原核表达HCV胞膜蛋白E2制备的多克隆抗体能特异性识别E2蛋白。为进一步开展HCVE2蛋白功能和HCV受体的研究奠定了基础。 Objective To express the envelop protein E2 of HCV and preparation of its polyclonal antibody. Methods The 831bp (384-661aa) fragment of HCV envelope proteins E2 gene was amplified by polymerase chain reaction (PCR) and cloned into the expression vector pET32a. Induced by IPTG, the soluble protein of interest could be obtained. The protein was purified by metal chelate affinity chromatography. The titer and specificity of polyclonal antibody were detected by indirect ELISA assay and Western blotting. Results The polyclonal antibody was induced by HCV E2 protein. The thin layer scanning showed that its purity reached at least 90%. The titer of antiserum was as high as 1: 1280, and the very high specificity was detected by Westem blotting. Conclusion Through IPTG induction and metal chelate affinity chromatography purification, the soluble HCV E2 protein with high purity and its specific antibody have been obtained. This study settles a foundation for investigating the function of HCV envelope proteins and studying the interaction of HCV envelope proteins with their receptors on the surface of cells.
出处 《中国全科医学》 CAS CSCD 2005年第22期1834-1836,共3页 Chinese General Practice
基金 国家自然科学基金(30070687)
关键词 肝炎病毒 胞膜蛋白 融合表达 金属螯合亲和层析 多克隆抗体 Hepatitis C virus Envelop protein Fusion expression Metal chelate affinity chromatography Polyclonal antibody
  • 相关文献

参考文献15

  • 1Lauer GM,Walker BD.Hepatitis C virus infection[J].N Engl J Med,2001,345(1):41-52.
  • 2李刚.郑州地区不同人群HCV感染及HCV基因型研究[J].中国误诊学杂志,2004,4(3):343-345. 被引量:10
  • 3Penin F,DubuissonJ,Rey FA,et al.Structural Biology of Hepatitis C Virus[J].Hepatology,2004,39(1):5-19.
  • 4Kuhn RJ,Zhang W,Rossmann MG,et al.Structure of dengue virus:implications for flavivirus organization,maturation and fusion[J].Cell,2002,108(5):717-725.
  • 5Bartosch B,Dubuisson J,Cosset FL.Infectious hepatitis C pseudoviruses containing functional E1E2 envelope protein complexes[J].Exp Med,2003,197(5):633-642.
  • 6杜德伟,贾战生,秦鸿雁,刘秋平,周永兴,韩骅.HCV包膜糖蛋白E2基因的克隆、蛋白表达及纯化[J].世界华人消化杂志,2004,12(2):315-318. 被引量:1
  • 7Drummer HE,Wilson KA,Poumbourios P.Determinants of CD81dimerization and interaction with hepatitis C virus glycoprotien E2 [J].Biochem biophys res Commun,2005,328(1):251-257.
  • 8VanCompernolle SE,Wiznycia AV,Rush JR,et al.Small molecule inhibition of hepatitis C virus E2 binding to CD81[J].Virology,2003,314(1):371-380.
  • 9Bartosch B,Vitelli A,Granier C,et al.Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor[J].J Biol Chem,2003,278(43):41624-41630.
  • 10Scarselli E,Ansuini H,Cerino R,et al.The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus[J].EMBO J,2002,21(19):5017 -5025.

二级参考文献21

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部